Adam Tomasi
President en ALLAKOS INC. .
Fortuna: 779 011 $ al 31/03/2024
Perfil
El Dr. Adam L. Tomasi es presidente y director de operaciones de Allakos, Inc. Forma parte del Consejo de Administración de Attune Pharmaceuticals, Inc. El Dr. Tomasi trabajó anteriormente como Director Científico en ZS Pharma, Inc., como Director en Alta Partners Management Corp. y como Químico Medicinal en Cytokinetics, Inc. y como Químico Medicinal en Gilead Sciences, Inc. Se licenció en la Universidad de California, Berkeley, obtuvo un MBA en la MIT Sloan School of Management y un doctorado en la Universidad de California, Irvine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALLAKOS, INC.
0.70% | 05/03/2024 | 618 263 ( 0.70% ) | 779 011 $ | 31/03/2024 |
Cargos activos de Adam Tomasi
| Empresas | Cargo | Inicio |
|---|---|---|
| ALLAKOS INC. | President | 01/08/2019 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Director/Board Member | - |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Director/Board Member | - |
Antiguos cargos conocidos de Adam Tomasi.
| Empresas | Cargo | Fin |
|---|---|---|
| ZS PHARMA INC | Chief Tech/Sci/R&D Officer | 01/03/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Private Equity Investor | - |
Formación de Adam Tomasi.
| University of California, Berkeley | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| ALLAKOS INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
- Bolsa de valores
- Insiders
- Adam Tomasi
